A group of researchers is drawing scientific attention to “seasonal psychology,” revealing useful new ways to improve your mental and physical health, especially in winter.

The FDA has approved a new drug, zanidatamab, for adults with advanced biliary tract cancer, or BTC. Marketed under the brand name Ziihera, it is a first-of-a-kind treatment for patients with ...

The FDA has granted fast-track approval for a groundbreaking gene therapy indicated for a rare genetic disorder called ...

In the U.S., the least active 25% of the population over 40 could add 11 years to their average life expectancy if they were ...

Of course, many Americans now work from home (or hybrid-style). But dozens of other at-home activities are also on the rise, according to new survey data from the U.S. Census program. For the average ...

As the FDA issues a new warning about aspiration across all GLP-1 weight loss drugs, doctor groups are giving new ...

With your doctor’s recommendation, exploring yoga as a remedy for low back pain is now easier than ever – giving you the ...

This fall, the CDC launched a new program to help reduce diagnostic errors, a leading cause of death in the U.S. Learn how to ...

New devices promise to help realign your body’s circadian rhythm for better health, but do they work? Here’s what the experts ...

About 6 in 10 people say they probably won’t get an updated shot this year, despite the CDC’s recommendation that everyone do so, according to results of a new survey from the Pew Research Center.

The FDA has approved a new drug called revumenib that can be taken orally to treat acute leukemia in patients 1 year or older. The drug will be marketed under the brand name Revuforj. Revuforj ...

Nov. 19, 2024 – Dieting is as American as, well, apple pie. More than half of us want to lose weight at any given time, surveys show, and about a quarter are actually trying to. But success ...